Medifocus Inc V.MFS

Primary Symbol: MDFZF

Healthcare Biotechnology

Medifocus Inc develops and sells minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate, medically known as Benign Prostate Hyperplasia (BHP). It owns two focused heat technology platforms, The Endo-thermotherapy Platform-from which Prolieve was developed, can be used to treat cancers in prostate, rectal, cervical and esophageal, and The Adaptive Phased Array Microwave Focusing Platform which directs precisely focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. The company through its operations generates revenue from the United States.

EXPM:MDFZF - Post by User

Medifocus Inc

Bullboard Posts

Comment by Highrider7on Mar 04, 2014 12:01pm

111 Views

Post# 22278045

RE:Answer the question.

" bayoubucks " .... I am saying that it is a good possibility as quite often this is what happens when a penny stock does a financing. It makes it easier to complete the financing when the stock price is being held at a higher level. And quite often after the financing is complete then the stock will retrace to lower levels. This may or may not be the case here. We will know a couple of months or so after the financing is complete ... assuming of course that it gets completed . Right now no-one even knows for sure if it will even get completed.

So now answer my question " bayoubucks " ..... With MFS's present burn rate how many more financings are going to be required before the Level 3 trials are complete ???

Bullboard Posts

Market Open Tues. Jan 14: Investors Eye U.S. CPI Data for Inflation Clues